Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)

By Rutkowski Piotr   Nowecki Zbigniew   Dębiec-Rychter Maria   Grzesiakowska Urszula   Michej Wanda   Woźniak Agnieszka   Siedlecki Janusz   Limon Janusz   Dobosz Anna   Kąkol Michał   Osuch Czesław   Ruka Włodzimierz  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 9, 2007-09 ,pp. : 589-597

Springer Publishing Company

Access to resources Recommend Favorite

Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib

By Andtbacka Robert   Ng Chaan   Scaife Courtney   Cormier Janice   Hunt Kelly   Pisters Peter   Pollock Raphael   Benjamin Robert   Burgess Michael   Chen Lei   Trent Jonathan   Patel Shreyaskumar   Raymond Kevin   Feig Barry  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 93-108

Bentham Science Publishers

Access to resources Recommend Favorite

Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment

By Koyama Tomoki   Nimura Hiroshi   Kobayashi Katsutoshi   Marushima Hideki   Odaira Hironori   Kashimura Hirotaka   Mitsumori Norio   Yanaga Katsuhiko  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 235-239

Springer Publishing Company

Access to resources Recommend Favorite

Should Surgical Resection Be Combined with Imatinib Therapy for Locally Advanced or Metastatic Gastrointestinal Stromal Tumors?

By Yoon Sam   Tanabe Kenneth  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1784-1786

Springer Publishing Company

Access to resources Recommend Favorite